Dual-optic curvature-changing modular-design presbyopic IOL

Session Details

Session Title: New IOL Optic Design

Session Date/Time: Tuesday 17/09/2019 | 16:30-18:00

Paper Time: 16:48

Venue: Free Paper Forum: Podium 1

First Author: : U.Devgan USA

Co Author(s): :    T. Kohnen   E. Donnenfeld   K. Solomon   S. Garg   R. Braga-Mele                 

Abstract Details

Purpose:

To design a novel IOL for cataract surgery which effectively addresses presbyopia by changing the curvature of a fluid-filled lens to increase the dioptric power.

Setting:

The lens has been in development for many years with the first human implantations done approximately 5 years ago in the setting of a clinical trial. The lens is called the Juvene and it is made by LensGen which is based in California, USA.

Methods:

We designed a dual optic lens which consists of two parts: a large, stationary base lens which completely fills the capsular bag and an anteriorly-placed, fluid-filled power lens which changes curvature to increase the power to give a wide range of vision without spectacles. The optics are clear and without diffractive rings or other aberration-inducing issues.

Results:

Initial clinical trials of the newest iteration of the Juvene lens have shown three or more diopters of focal range, thereby giving an effective treatment for presbyopia while maintaining excellent distance visual acuity.

Conclusions:

The Juvene IOL from LensGen has promising initial results where study patients achieved three or more diopters of visual range.

Financial Disclosure:

gains financially from product or procedure presented, travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, receives non monetary benefits from a company producing, developing or supplying the product or procedure presented, receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented, has significant investment interest in a company producing, developing or supplying product or procedure presented